Symbol
CYCN on Nasdaq
Investment type
Equity / Common Stock, no par value
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%
Shares, Excluding Options vs Price
Value, Excluding Options

Slate Path Capital LP ownership in Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN)

06 Dec 2024 - Slate Path Capital LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN). This represents 0% ownership of the company. This is the first filing by Slate Path Capital LP disclosing ownership of Cyclerion Therapeutics, Inc. Common Stock, no par value (CYCN).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.